Accuracy and Precision of Partial-Volume Correction in Oncological PET/CT Studies

Accurate quantification of tracer uptake in small tumors using PET is hampered by the partial-volume effect as well as by the method of volume-of-interest (VOI) delineation. This study aimed to investigate the effect of partial-volume correction (PVC) combined with several VOI methods on the accuracy and precision of quantitative PET. Methods: Four image-based PVC methods and resolution modeling (applied as PVC) were used in combination with several common VOI methods. Performance was evaluated using simulations, phantom experiments, and clinical repeatability studies. Simulations were based on a whole-body 18F-FDG PET scan in which differently sized spheres were placed in lung and mediastinum. A National Electrical Manufacturers Association NU2 quality phantom was used for the experiments. Repeatability data consisted of an 18F-FDG PET/CT study on 11 patients with advanced non–small cell lung cancer and an 18F-fluoromethylcholine PET/CT study on 12 patients with metastatic prostate cancer. Results: Phantom data demonstrated that most PVC methods were strongly affected by the applied resolution kernel, with accuracy differing by about 20%–50% between full-width-at-half-maximum settings of 5.0 and 7.5 mm. For all PVC methods, large differences in accuracy were seen among all VOI methods. Additionally, the image-based PVC methods were observed to have variable sensitivity to the accuracy of the VOI methods. For most PVC methods, accuracy was strongly affected by more than a 2.5-mm misalignment of true (simulated) VOI. When the optimal VOI method for each PVC method was used, high accuracy could be achieved. For example, resolution modeling for mediastinal lesions and iterative deconvolution for lung lesions were 99% ± 1.5% and 99% ± 0.9% accurate, respectively, for spheres 15–40 mm in diameter. Precision worsened slightly for resolution modeling and to a larger extent for some image-based PVC methods. Uncertainties in delineation propagated into uncertainties in PVC performance, as confirmed by the clinical data. Conclusion: The accuracy and precision of the tested PVC methods depended strongly on VOI method, resolution settings, contrast, and spatial alignment of the VOI. PVC has the potential to substantially improve the accuracy of tracer uptake assessment, provided that robust and accurate VOI methods become available. Commonly used delineation methods may not be adequate for this purpose.

[1]  Ian Poon,et al.  Symmetric geometric transfer matrix partial volume correction for PET imaging: principle, validation and robustness , 2012, Physics in medicine and biology.

[2]  Gregory M. Szilagyi,et al.  Region-Based Partial Volume Correction Techniques for PET Imaging: Sinogram Implementation and Robustness , 2013, International journal of molecular imaging.

[3]  I. Buvat,et al.  Partial-Volume Effect in PET Tumor Imaging* , 2007, Journal of Nuclear Medicine.

[4]  Dimitris Visvikis,et al.  A novel partial volume effects correction technique integrating deconvolution associated with denoising within an iterative PET image reconstruction. , 2015, Medical physics.

[5]  K. Herholz,et al.  Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.

[6]  Arman Rahmim,et al.  Resolution modeling in PET imaging: Theory, practice, benefits, and pitfalls. , 2013, Medical physics.

[7]  A. Lammertsma,et al.  Monitoring response to therapy in cancer using [18F]-2-fluoro-2-deoxy-d-glucose and positron emission tomography: an overview of different analytical methods , 2000, European Journal of Nuclear Medicine.

[8]  Habib Zaidi,et al.  Partial Volume Correction Strategies in PET. , 2007, PET clinics.

[9]  Eric J. W. Visser,et al.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0 , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[10]  J Daouk,et al.  Respiratory-gated positron emission tomography and breath-hold computed tomography coupling to reduce the influence of respiratory motion: Methodology and feasibility , 2009, Acta radiologica.

[11]  R. Wahl,et al.  From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors , 2009, Journal of Nuclear Medicine.

[12]  S. Libutti,et al.  Partial-Volume Correction in PET: Validation of an Iterative Postreconstruction Method with Phantom and Patient Data , 2007, Journal of Nuclear Medicine.

[13]  Liane Oehme,et al.  A method for model-free partial volume correction in oncological PET , 2012, EJNMMI Research.

[14]  R. Boellaard,et al.  Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  R. Boellaard,et al.  Repeatability of Quantitative 18F-Fluoromethylcholine PET/CT Studies in Prostate Cancer , 2016, The Journal of Nuclear Medicine.

[16]  Jerry L Prince,et al.  Measurement of Radiotracer Concentration in Brain Gray Matter Using Positron Emission Tomography: MRI-Based Correction for Partial Volume Effects , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  M Schwaiger,et al.  Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  Anthonin Reilhac,et al.  Deconvolution-based partial volume correction in Raclopride-PET and Monte Carlo comparison to MR-based method , 2008, NeuroImage.

[19]  I. Castiglioni,et al.  A Partial Volume Effect Correction Tailored for 18F-FDG-PET Oncological Studies , 2013, BioMed research international.

[20]  Recovery coefficients determination for partial volume effect correction in oncological PET/CT images considering the effect of activity outside the field of view , 2013, Annals of Nuclear Medicine.

[21]  Jan Axelsson,et al.  Subcentimeter Tumor Lesion Delineation for High-Resolution 18F-FDG PET Images: Optimizing Correction for Partial-Volume Effects , 2013, The Journal of Nuclear Medicine Technology.

[22]  A. Evans,et al.  Correction for partial volume effects in PET: principle and validation. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[23]  Nico Karssemeijer,et al.  A novel iterative method for lesion delineation and volumetric quantification with FDG PET , 2007, Nuclear medicine communications.

[24]  I. Buvat,et al.  A review of partial volume correction techniques for emission tomography and their applications in neurology, cardiology and oncology , 2012, Physics in medicine and biology.

[25]  Ronald Boellaard,et al.  Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study. , 2014, Radiology.

[26]  Lilli Geworski,et al.  Recovery correction for quantitation in emission tomography: a feasibility study , 2000, European Journal of Nuclear Medicine.

[27]  Malek Adjouadi,et al.  An algorithm for PET tumor volume and activity quantification: without specifying camera's point spread function (PSF). , 2012, Medical physics.

[28]  R. Boellaard,et al.  Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis , 2015, European Journal of Nuclear Medicine and Molecular Imaging.

[29]  D. Visvikis,et al.  Incorporation of wavelet-based denoising in iterative deconvolution for partial volume correction in whole-body PET imaging , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[30]  E. Hoffman,et al.  Quantitation in Positron Emission Computed Tomography: 1. Effect of Object Size , 1979, Journal of computer assisted tomography.

[31]  Joel Karp,et al.  Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.